Nudging epidermal field cancerogenesis by imiquimod.

Administration, Topical; Aged; Aminoquinolines/therapeutic use; Antineoplastic Agents/therapeutic use; Biopsy; Bowen's Disease/drug therapy/pathology; Carcinoma, Basal Cell/drug therapy/pathology; Humans; Keratinocytes/drug effects; Middle Aged; Neoplasms, Multiple Primary/drug therapy/pathology; Skin/pathology; Skin Neoplasms/drug therapy/pathology; Treatment Outcome

Abstract :

[en] BACKGROUND: The coexistence of malignancies close to each other on the skin has been occasionally reported. The concept of field cancerogenesis applies to such cases. Given the purported mechanism of action of imiquimod, it should not be surprising that this treatment could inhibit epidermal field cancerogenesis. AIM: To assess the effect of imiquimod applied twice weekly on incipient bowenoid changes disclosed in the vicinity of basal cell carcinomas. MATERIALS AND METHOD: Biopsies were taken before treatment and after 4-6 weeks and 12 weeks of imiquimod treatment. RESULTS: Large atypical bowenoid keratinocytes and dyskeratotic cells were cleared in time while factor-XIIIa-positive dermal dendrocytes appeared boosted and admixed with a brisk lymphocytic infiltration. CONCLUSION: Epidermal field cancerogenesis appears to be controlled by imiquimod. Dermal dendrocytes might play a pivotal role in this regression phenomenon.

Disciplines :

Dermatology

Author, co-author :

Uhoda, Isabelle; Centre Hospitalier Régional de Huy > Dermatologie

Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

English

Title :

Nudging epidermal field cancerogenesis by imiquimod.

Publication date :

2003

Journal title :

Dermatology

ISSN :

1018-8665

eISSN :

1421-9832

Publisher :

S. Karger, Basel, Switzerland

Volume :

206

Issue :

Pages :

357-60

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 11 March 2009

Statistics

Number of views

74 (2 by ULiège)

Number of downloads

1 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Woodhead, A.D., Setlow, R.B., Tanaka, M., Environmental factors in nonmelanoma and melanoma skin cancer (1999) J Epidemiol, 9 (SUPPL. 6), pp. S102-S114
Bhawan, J., Mehregan, A.H., Jung-Legg, Y., Gellis, S.E., Pigmented basal cell carcinoma and superficial spreading malignant melanoma: An unusual combination (1984) J Cutan Pathol, 11, pp. 471-475
Coskey, R.J., Mehregan, A.H., The association of basal cell carcinomas with other tumors (1987) J Dermatol Surg Oncol, 13, pp. 553-555
Sina, B., Samorodin, C., Basal cell carcinoma surrounded by lentigo maligna (1989) Cutis, 44, pp. 81-82
Schallreuter, K.U., Levening, C., Berger, J., Cutaneous malignant melanomas with other coexisting neoplasms: A true association? (1993) Dermatology, 186, pp. 12-17
Boyd, A.S., Rapini, R.P., Cutaneous collision tumors: An analysis of 69 cases and review of the literature (1994) Am J Dermatopathol, 16, pp. 253-257
Marghoob, A.A., Slade, J., Kopf, A.W., Salopek, T.G., Rigel, D.S., Bart, R.S., Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: A case-control study (1996) Br J Dermatol, 135, pp. 704-711
Levi, F., La Vecchia, C., Randimbison, L., Te, V.C., Erler, G., Incidence of invasive cancers following cutaneous malignant melanoma (1997) Int J Cancer, 72, pp. 776-779
Piérard, G.E., Fazaa, B., Henry, F., Kamoun, M.R., Piérard-Franchimont, C., Collision of primary malignant neoplasms of the skin: The malignant melanoma-basal cell carcinoma connection (1997) Dermatology, 194, pp. 378-379
Savoia, P., Quaglino, P., Verrone, A., Bernengo, M.G., Multiple primary melanomas: Analysis of 49 cases (1998) Melanoma Res, 8, pp. 361-366
Wassberg, C., Thorn, M., Yuen, J., Ringborg, U., Hakulinen, T., Second primary cancers in patients with squamous cell carcinoma of the skin: A population based study in Sweden (1999) Int J Cancer, 80, pp. 511-515
Bower, C.P., Lear, J.T., Bygrave, S., Etherington, D., Harvey, I., Archer, C.B., Basal cell carcinoma and risk of subsequent malignancies: A cancer registry-based study in southwest England (2000) J Am Acad Dermatol, 42, pp. 988-991
Hemminki, K., Dong, C., Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin (2000) Arch Dermatol, 136, pp. 647-651
Milan, T., Pukkala, E., Verkasalo, P.K., Kaprio, J., Jansen, C.T., Koskenvuo, M., Teppo, L., Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995 (2000) Int J Cancer, 87, pp. 283-288
Slaughter, D.P., Southwick, H.W., Smejkal, W., 'Field cancerization' in oral stratified squamous epithelium: Clinical implications of multicentric origin (1953) Cancer, 6, pp. 963-968
Sagman, U., Lishner, M., Maki, E., Shepherd, F.A., Haddad, R., Evans, W.K., De Boer, G., Yeoh, J.L., Second primary malignancies following diagnosis of small-cell lung cancer (1992) J Clin Oncol, 10, pp. 1525-1533
Carlson, J.A., Scott, D., Wharton, J., Sell, S., Incidental histopathologic pattern: Possible evidence of 'field cancerisation' surrounding skin tumors (2001) Am J Dermatopathol, 23, pp. 494-497
Guenthner, S.T., Hurwitz, R.M., Buckel, L.J., Gray, H.R., Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: A clinicopathologic correlation (1999) J Am Acad Dermatol, 41, pp. 443-448
Carli, P., Massi, D., Santucci, M., Biggeri, A., Giannotti, B., Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: Results from a case-control study (1999) J Am Acad Dermatol, 40, pp. 549-557
Miller, R.L., Gerster, K.F., Owens, M.L., Slade, H.B., Tomai, M.A., Imiquimod applied topically: A novel immune response modifier and new class of drug (1999) Int J Immunopharmacol, 21, pp. 1-14
Sauder, D.N., Immunomodulatory and pharmacological properties of imiquimod (2000) J Am Acad Dermatol, 43, pp. S6-S11
Eedy, D.J., Imiquimod: A potential role in dermatology? (2002) Br J Dermatol, 147, pp. 1-6
Stockfleth, E., Meyer, T., Benninghoff, B., Christophers, E., Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases (2001) Br J Dermatol, 144, pp. 1050-1053
Persaud, A., Lebwohl, M., Imiquimod cream in the treatment of actinic keratoses (2002) J Am Acad Dermatol, 47, pp. S236-S239
Diaz-Arrastia, C., Arany, I., Robazetti, S.C., Dinh, T.V., Gatalica, Z., Tyring, S.K., Hannigan, E., Clinical and molecular responses in high-grade intraepithelial neoplasia treated with imiquimod 5% (2001) Clin Cancer Res, 7, pp. 3031-3033
Hengge, U.R., Stark, R., Topical imiquimod to treat intraepidermal carcinoma (2001) Arch Dermatol, 137, pp. 709-711
Mackenzie-Wood, A., Kossard, S., De Launey, J., Wilkinson, B., Owens, M.I., Imiquimod 5% cream in the treatment of Bowen's disease (2001) J Am Acad Dermatol, 44, pp. 462-470
Cook-Bolden, F., Weinberg, J.M., Topical imiquimod 5% cream in the treatment of Bowen's disease of the penis (2002) J Am Acad Dermatol, 46, pp. 146-147
Gutzmer, R., Kaspari, M., Vogelbruch, M., Kiehl, P., Kapp, A., Werfel, T., Brodersen, J.P., Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry (2002) Br J Dermatol, 147, pp. 160-165
Thai, K.E., Sinclair, R.D., Treatment of Bowen's disease of the penis with imiquimod (2002) J Am Acad Dermatol, 46, pp. 470-471
Schroeder, T.L., Sengelmann, R.D., Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream (2002) J Am Acad Dermatol, 46, pp. 545-548
Kagy, M.K., Amonette, R., The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell naevus syndrome patient (2000) Dermatol Surg, 26, pp. 577-578
Marks, R., Gebauer, K., Shumack, S., Amies, M., Bryden, J., Fox, T.I., Owens, M.L., Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicentre 6-week dose-response trial (2001) J Am Acad Dermatol, 44, pp. 807-813
Quatresooz, P., Piérard, G.E., Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes Clin Exp Dermatol, , in press
Arrese, J.E., Paquet, P., Claessens, N., Piérard-Franchimont, C., Piérrard, G.E., Dermal dendritic cells in anogenital warty lesions unresponsive to an immune-response modifier (2001) J Cutan Pathol, 28, pp. 131-134
Hermanns-Lê, T., Paquet, P., Nikkels, A.F., Piérard-Franchimont, C., Piérard, G.E., Prolonged imiquimod treatment and graft-versus-host reaction: Histological mimicry in the skin infiltration pattern of the monocyte-macrophage-dendrocyte lineage (2003) Dermatology, 206, pp. 361-365
Zipori, D., Stroma cells in tumor growth and regression (1990) Cancer J, 3, pp. 164-169
Al-Saleh, W., Delvenne, P., Arrese, J.A., Nikkels, A.F., Piérard, G.E., Boniver, J., Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix (1995) Virchows Arch, 27, pp. 41-48
Arrese, J.E., Piérard, G.E., Factor XIIIa-positive dendrocytes and the dermal microvascular unit (1990) Dermatologica, 180, pp. 51-53
Piérard-Franchimont, C., Arrese, J.E., Nikkels, A.F., Al-Saleh, W., Delvenne, P., Piérard, G.E., Factor XIIIa-positive dermal dendrocytes and proliferative activity of cutaneous cancers (1996) Virchows Arch, 429, pp. 43-48